[go: up one dir, main page]

Eysselein et al., 1987 - Google Patents

Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood.

Eysselein et al., 1987

View HTML
Document ID
4836359004684959334
Author
Eysselein V
Eberlein G
Hesse W
Singer M
Goebell H
Reeve Jr J
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

Cholecystokinin-58 (CCK-58) is the largest and most abundant, biologically active form of cholecystokinin in canine intestinal mucosa. Despite the high amounts in mucosa, CCK-58 has not been detected in significant amounts in the circulation. The release of CCK-58 into …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]

Similar Documents

Publication Publication Date Title
Eysselein et al. Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood.
Blackburn et al. A radioimmunoassay for neurotensin in human plasma
Christophe et al. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide.
McMartin et al. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity
Liddle et al. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol
Feurle et al. Identification of xenin, a xenopsin-related peptide, in the human gastric mucosa and its effect on exocrine pancreatic secretion.
Chang et al. Radioimmunoassay of cholecystokinin
Raufman et al. Actions of Gila monster venom on dispersed acini from guinea pig pancreas
Anagnostides et al. Sham feeding and pancreatic secretion: evidence for direct vagal stimulation of enzyme output
Knuhtsen et al. Gastrin-releasing peptide: effect on exocrine secretion and release from isolated perfused porcine pancreas
Pappas et al. Peptide YY: metabolism and effect on pancreatic secretion in dogs
Eberlein et al. Detection of cholecystokinin-58 in human blood by inhibition of degradation
Werner et al. High levels of vasoactive intestinal peptide in human milk
Hoffmann et al. Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogs
Hamscher et al. Distribution, formation, and molecular forms of the peptide xenin in various mammals
Shively et al. CCK-5: sequence analysis of a small cholecystokinin from canine brain and intestine
Izzo et al. Immunoreactive cholecystokinin in human and rat plasma: correlation of pancreatic secretion in response to CCK
CHRISTOFIDES et al. Distribution of PHI in the rat brain
Gores et al. Hepatic processing of cholecystokinin peptides. II. Cellular metabolism, transport, and biliary excretion
Eysselein et al. Molecular variants of cholecystokinin after endogenous stimulation in humans: a time study
Otsuki et al. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas
Weber et al. Specific binding and degradation of somatostatin by membrane vesicles from pig gut
Holst et al. Somatostatin restraint of gastrin secretion in pigs revealed by monoclonal antibody immunoneutralization
Anderson et al. Characterization of the endogenous intestinal peptide that stimulates the rectal gland of Scyliorhinus canicula
Beardshall et al. Effect of chymotrypsin on human cholecystokinin release: use of clostripain in the validation of a new radioimmunoassay